In a large PPMS population that included older patients and people with more advanced disease, ocrelizumab led to a 30% risk ...

Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

Aerobic exercise may promote myelin repair in some parts of the brain in people with multiple sclerosis (MS), according to a ...

Doctors in Cambridge believe they are “on the brink of a new class of treatments” for multiple sclerosis (MS) after a trial ...

Increasing blood vitamin D levels with high-dose supplementation shows promise for people with first symptoms suggestive of ...

A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective ...

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition.

The 2024 McDonald criteria, published just before the 2025 ECTRIMS Congress, substantially expand criteria for a probable ...

Doctors could be able to spot people who are at higher risk of multiple sclerosis (MS) sooner after a new study helped to ...

Decarlos Brown Jr. had harbored paranoid delusions for years, yet under state law he was not considered dangerous enough to ...

A major UK study has revealed that the early warning signs of multiple sclerosis (MS)—including pain, mood changes, and ...

Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS ...